Welcome to LookChem.com Sign In|Join Free
  • or
Pravastatin 6'-Ketone Sodium Salt is a chemical compound derived from Pravastatin Sodium, a competitive inhibitor of HMG-CoA reductase. It is an impurity found in Pravastatin Sodium and has potential applications in the pharmaceutical industry.

201423-59-8

Post Buying Request

201423-59-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

201423-59-8 Usage

Uses

Used in Pharmaceutical Industry:
Pravastatin 6'-Ketone Sodium Salt is used as a drug for lowering cholesterol and preventing cardiovascular disease. It functions by inhibiting the enzyme HMG-CoA reductase, which plays a crucial role in cholesterol synthesis, thereby reducing the levels of low-density lipoprotein (LDL) cholesterol or "bad" cholesterol in the blood. This helps in maintaining healthy cholesterol levels and reducing the risk of heart disease and stroke.

Check Digit Verification of cas no

The CAS Registry Mumber 201423-59-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,1,4,2 and 3 respectively; the second part has 2 digits, 5 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 201423-59:
(8*2)+(7*0)+(6*1)+(5*4)+(4*2)+(3*3)+(2*5)+(1*9)=78
78 % 10 = 8
So 201423-59-8 is a valid CAS Registry Number.

201423-59-8Upstream product

201423-59-8Downstream Products

201423-59-8Relevant academic research and scientific papers

Metabolism of pravastatin sodium by 3α-hydroxysteroid dehydrogenase

Muramatsu, Shigeki,Komokata, Yuko,Tanaka, Yorihisa,Takahagi, Hidekuni

, p. 1199 - 1203 (2007/10/03)

When incubated with isolated rat hepatocytes, pravastatin sodium (PS) yielded a small amount of a metabolite in addition to two major metabolites that have already been reported. The previously uncharacterized metabolite was found to be formed by at first being enzymatically dehydrogenated to 6'- keto intermediate (R-104), followed by decomposition to give the aromatized metabolite (R-195), through spontaneous deesterification with accompanying aromatization. The PS-6'β-hydroxydehydrogenase activity was localized in cytosolic fraction and required NADP, preferentially over NAD, as a cofactor. The formation of R-195 by rat liver cytosol was strongly inhibited by indomethacin, 3α-hydroxysteroids (but not 3β-isomers) and 3-ketosteroids. The results and high substrate specificity of purified PS-6'β- hydroxydehydrogenase toward 3α-hydroxysteroids suggested that the enzyme is identical to 3α-hydroxysteroid dehydrogenase.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 201423-59-8